Healthcare -
Biotechnology - NASDAQ - US
$ 20.59
0.869 %
$ 15.2 B
Market Cap
-58.03
P/E
SMMT - OPERATING INCOME
Operating Income SMMT - Summit Therapeutics Inc.
313 K
LAST VALUE
41.57%
2 YEAR CAGR
14.95%
5 YEAR CAGR
7.26%
10 YEAR CAGR